Allspring Global Investments Holdings LLC decreased its holdings in Stryker Corporation (NYSE: SYK) by 32.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,408 shares of the medical technology company's stock after selling 7,373 shares during the quarter. Allspring Global Investments

Runnymede Capital Advisors Inc. bought a new position in shares of Stryker Corporation (NYSE: SYK) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 9,255 shares of the medical technology company's stock, valued at approximately $3,253,000. Stryker comprises about 1.9% of Runnymede Capital Advisors

Savvy Advisors Inc. increased its position in shares of Stryker Corporation (NYSE: SYK) by 81.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,630 shares of the medical technology company's stock after acquiring an additional 2,523 shares during the period. Savvy Advisors

IM Cannabis (NASDAQ: IMCC - Get Free Report) and Stryker (NYSE: SYK - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability. Profitability This table compares IM Cannabis and Stryker's net

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Portage, Michigan, April 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2026 on Thursday, April 30, 2026.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter that ended March 31, 2026.

Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026. Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company.

Beacon Investment Advisory Services Inc. lessened its holdings in Stryker Corporation (NYSE: SYK) by 4.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 60,194 shares of the medical technology company's stock after selling 2,520 shares during the period. Beacon Investment Advisory Services Inc.'s holdings

Chesley Taft and Associates LLC raised its holdings in Stryker Corporation (NYSE: SYK) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 141,083 shares of the medical technology company's stock after purchasing an additional 3,230 shares during the quarter. Stryker

Bonness Enterprises Inc. lessened its stake in Stryker Corporation (NYSE: SYK) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,939 shares of the medical technology company's stock after selling 1,550 shares during the period. Stryker comprises